A New Insight into the Surgical Treatment of Primary Macronodular Adrenal Hyperplasia

Carregando...
Imagem de Miniatura
Citações na Scopus
17
Tipo de produção
article
Data de publicação
2020
Título da Revista
ISSN da Revista
Título do Volume
Editora
ENDOCRINE SOC
Citação
JOURNAL OF THE ENDOCRINE SOCIETY, v.4, n.8, article ID bvaa083, 14p, 2020
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
Purpose: This prospective study presents the results of a new approach in the treatment of primary macronodular adrenal hyperplasia (PMAII), with simultaneous total adrenalectomy of the larger adrenal gland and partial adrenalectomy of the contralateral adrenal gland (adrenal-sparing surgery). Materials and Methods: We performed a prospective study including 17 patients with PMAH treated surgically with adrenal-sparing surgery in a tertiary referral hospital, with a median follow-up of 41 months. Clinical, hormonal, and genetic parameters were evaluated before surgery and during follow-up. All patients had at least 1 radiological examination before and after the procedure. Results: Among the 17 patients, all but 1 patient had complete hypercortisolism control, and 12 recovered normal adrenal function after surgery. Significant improvement in clinical parameters was observed: weight loss (P = .004); reduction of both systolic (P = .001) and diastolic (P = .001) blood pressure; and reduction in the number of antihypertensive drugs (P < .001). Intra-, peri-, and postoperative complications were not observed. Conclusion: Adrenal-sparing surgery is a safe and feasible procedure to treat patients with PMAH, providing a substantial chance of hypercortisolism control without the disadvantages of lifetime corticosteroid replacement. (C) Endocrine Society 2020.
Palavras-chave
PMAH, partial adrenalectomy, hypercortisolism, adrenal surgery, ARMC5
Referências
  1. Albiger NM, 2015, CLIN ENDOCRINOL, V82, P808, DOI 10.1111/cen.12763
  2. Alencar GA, 2014, J CLIN ENDOCR METAB, V99, pE1501, DOI 10.1210/jc.2013-4237
  3. Alencar GA, 2011, J CLIN ENDOCR METAB, V96, P3300, DOI 10.1210/jc.2011-1397
  4. Assie G, 2013, NEW ENGL J MED, V369, P2105, DOI 10.1056/NEJMoa1304603
  5. Brauckhoff M, 2003, SURGERY, V134, P1020, DOI 10.1016/j.surg.2003.08.005
  6. Cavalcante IP, 2016, ACTA RADIOL, V57, P370, DOI 10.1177/0284185115575195
  7. CHARLSON M, 1994, J CLIN EPIDEMIOL, V47, P1245, DOI 10.1016/0895-4356(94)90129-5
  8. CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8
  9. Debillon E, 2015, J CLIN ENDOCR METAB, V100, P4417, DOI 10.1210/jc.2015-2662
  10. Di Dalmazi G, 2014, J CLIN ENDOCR METAB, V99, P2637, DOI 10.1210/jc.2014-1401
  11. Erichsen MM, 2009, EUR J ENDOCRINOL, V160, P233, DOI 10.1530/EJE-08-0550
  12. Iacobone M, 2008, WORLD J SURG, V32, P882, DOI 10.1007/s00268-007-9408-5
  13. Kaye DR, 2010, J UROLOGY, V184, P18, DOI 10.1016/j.juro.2010.03.052
  14. KIRSCHNER MA, 1964, J CLIN ENDOCR METAB, V24, P947, DOI 10.1210/jcem-24-10-947
  15. Lacroix A, 2004, TRENDS ENDOCRIN MET, V15, P375, DOI 10.1016/j.tem.2004.08.007
  16. Lacroix A, 2000, BRAZ J MED BIOL RES, V33, P1201, DOI 10.1590/S0100-879X2000001000010
  17. Lacroix A, 2009, BEST PRACT RES CL EN, V23, P245, DOI 10.1016/j.beem.2008.10.011
  18. Leong SH, 2018, ENDOCR PRACT, V24, P14, DOI 10.4158/EP-2017-0074
  19. Lowery AJ, 2017, LANGENBECK ARCH SURG, V402, P775, DOI 10.1007/s00423-017-1569-6
  20. Mazzuco TL, 2009, ENDOCR J, V56, P867, DOI 10.1507/endocrj.K08E-370
  21. Nagai M, 1999, INTERNAL MED, V38, P969, DOI 10.2169/internalmedicine.38.969
  22. Nagaraja V, 2015, INT J SURG, V16, P7, DOI 10.1016/j.ijsu.2015.01.015
  23. Newell-Price J, 2006, LANCET, V367, P1605, DOI 10.1016/S0140-6736(06)68699-6
  24. Nieman LK, 2008, J CLIN ENDOCR METAB, V93, P1526, DOI 10.1210/jc.2008-0125
  25. Obata Y, 2011, INTERNAL MED, V50, P2621, DOI 10.2169/internalmedicine.50.5578
  26. Omori N, 2001, ENDOCR J, V48, P665, DOI 10.1507/endocrj.48.665
  27. Osswald A, 2019, J CLIN ENDOCR METAB, V104, P2985, DOI 10.1210/jc.2018-02204
  28. Prete A, 2017, ENDOCRINE, V55, P969, DOI 10.1007/s12020-016-1007-5
  29. Rushworth RL, 2019, NEW ENGL J MED, V381, P852, DOI 10.1056/NEJMra1807486
  30. Srougi V, 2016, UROLOGY, V90, P217, DOI 10.1016/j.urology.2015.11.043
  31. Tabarin A, 2018, ANN ENDOCRINOL-PARIS, V79, P146, DOI 10.1016/j.ando.2018.03.013
  32. Zhang YS, 2015, INT J CLIN EXP MED, V8, P19311